These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 18591440)

  • 1. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Valeti U; Nishimura RA; Ommen SR; Rihal CS; Gersh BJ; Hodge DO; Schaff HV; Holmes DR
    Circulation; 2008 Jul; 118(2):131-9. PubMed ID: 18591440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Buergler JM; Quinones MA; Spencer WH; Lawrie GM
    J Am Coll Cardiol; 2007 Aug; 50(8):795-8. PubMed ID: 17707185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
    Alam M; Dokainish H; Lakkis NM
    Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
    Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended myectomy for hypertrophic obstructive cardiomyopathy after failure or contraindication of septal ablation or with combined surgical procedures.
    Dörge H; Schmitto JD; Liakopoulos OJ; Walther S; Schöndube FA
    Thorac Cardiovasc Surg; 2004 Dec; 52(6):344-8. PubMed ID: 15573275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Ommen SR; Holmes DR; Dearani JA; Rihal CS; Gersh BJ; Lennon RJ; Nishimura RA
    Circulation; 2012 Nov; 126(20):2374-80. PubMed ID: 23076968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: a Scandinavian multicenter study.
    Jensen MK; Almaas VM; Jacobsson L; Hansen PR; Havndrup O; Aakhus S; Svane B; Hansen TF; Køber L; Endresen K; Eriksson MJ; Jørgensen E; Amlie JP; Gadler F; Bundgaard H
    Circ Cardiovasc Interv; 2011 Jun; 4(3):256-65. PubMed ID: 21540441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment.
    Leonardi RA; Kransdorf EP; Simel DL; Wang A
    Circ Cardiovasc Interv; 2010 Apr; 3(2):97-104. PubMed ID: 20197511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy.
    Woo A; Williams WG; Choi R; Wigle ED; Rozenblyum E; Fedwick K; Siu S; Ralph-Edwards A; Rakowski H
    Circulation; 2005 Apr; 111(16):2033-41. PubMed ID: 15824202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution.
    ten Cate FJ; Soliman OI; Michels M; Theuns DA; de Jong PL; Geleijnse ML; Serruys PW
    Circ Heart Fail; 2010 May; 3(3):362-9. PubMed ID: 20332420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.
    McLeod CJ; Ommen SR; Ackerman MJ; Weivoda PL; Shen WK; Dearani JA; Schaff HV; Tajik AJ; Gersh BJ
    Eur Heart J; 2007 Nov; 28(21):2583-8. PubMed ID: 17483110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment modalities in hypertrophic obstructive cardiomyopathy: surgical myectomy versus percutaneous septal ablation.
    Vural AH; Tiryakioğlu O; Türk T; Ata Y; Ari H; Yalçinkaya S; Erkut B; Bozat T; Ozyazicioğlu A
    Heart Surg Forum; 2007; 10(6):493-7. PubMed ID: 18187386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of hypertrophic cardiomyopathy patients for myectomy or alcohol septal ablation.
    Lever HM
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():27-30. PubMed ID: 17162266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets.
    van der Lee C; ten Cate FJ; Geleijnse ML; Kofflard MJ; Pedone C; van Herwerden LA; Biagini E; Vletter WB; Serruys PW
    Circulation; 2005 Jul; 112(4):482-8. PubMed ID: 16027255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy.
    Minakata K; Dearani JA; Schaff HV; O'Leary PW; Ommen SR; Danielson GK
    Ann Thorac Surg; 2005 Sep; 80(3):851-6. PubMed ID: 16122442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Binder J; Nishimura RA; Holmes DR; Rihal CS; Gersh BJ; Bresnahan JF; Ommen SR
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E58-67. PubMed ID: 22511295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients.
    Maron BJ; Yacoub M; Dearani JA
    Eur Heart J; 2011 May; 32(9):1055-8. PubMed ID: 21324934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Golden jubilee of hypertrophic cardiomyopathy: is alcohol septal ablation the gold standard?
    Parakh N; Bhargava B
    Cardiovasc Revasc Med; 2009; 10(3):172-8. PubMed ID: 19595399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.